KLICKMER Trademark

Trademark Overview


On Friday, February 5, 2021, a trademark application was filed for KLICKMER with the United States Patent and Trademark Office. The USPTO has given the KLICKMER trademark a serial number of 79311991. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Immudex ApS. The KLICKMER trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Preparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relat...

Chemicals used in diagnostics, industry and science, other than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagents, monoclonal antibodies, reagents, diagnostic agents, control reagents, DNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for analysis for research pur...
klickmer

General Information


Serial Number79311991
Word MarkKLICKMER
Filing DateFriday, February 5, 2021
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6720843
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2022

Trademark Statements


Goods and ServicesPreparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccines, immunotherapeutics and cellular therapies, including cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy and other medical therapies, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases, and for use in connection with medical procedures and diagnosis, namely, transplantation, immune monitoring, and vaccines and T-cell monitoring
Goods and ServicesChemicals used in diagnostics, industry and science, other than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagents, monoclonal antibodies, reagents, diagnostic agents, control reagents, DNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for analysis for research purposes of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis for research purposes of infectious diseases, autoimmunity and for use in connection with toxicological studies and research in relation to transplantation, immune monitoring, vaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmudex ApS
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDK

Party NameImmudex ApS
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDK

Party NameImmudex ApS
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDK

Trademark Events


Event DateEvent Description
Friday, April 14, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 14, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 14, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, April 14, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 14, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 14, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, April 2, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, October 3, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 9, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 9, 2022FINAL DISPOSITION PROCESSED
Wednesday, August 24, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 24, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, February 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2022PUBLISHED FOR OPPOSITION
Sunday, February 20, 2022NOTIFICATION PROCESSED BY IB
Wednesday, February 2, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 2, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 4, 2021REFUSAL PROCESSED BY IB
Monday, September 13, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 13, 2021REFUSAL PROCESSED BY MPU
Wednesday, September 1, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 31, 2021NON-FINAL ACTION WRITTEN
Monday, August 30, 2021ASSIGNED TO EXAMINER
Tuesday, June 8, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, June 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 27, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB